You are here: Home » Companies » News
Business Standard

Lupin gets USFDA nod for generic cough relief oral solution

The product is generic version of Endo Pharmaceuticals Inc's Hycodan oral solution in same strength

Press Trust of India  |  New Delhi 

Lupin gets USFDA nod for generic cough relief oral solution

firm has received approval from the US health regulator for generic Hydrocodone Bitartrate and Homatropine Methylbromide oral solution used for providing relief of cough.

The company has received US Food and Administration (USFDA) approval for its generic Hydrocodone Bitartrate and Homatropine Methylbromide oral solution (Syrup) 5 mg/1.5 mg per 5 ml, said in a filing.



The product is generic version of Endo Pharmaceuticals Inc's Hycodan oral solution in the same strength, it added.

Hydrocodone Bitartrate and Homatropine Methylbromide is indicated for the symptomatic relief of cough in adults and children 6 years of age and older.

of Ltd today closed at Rs 1,440.15 per scrip on BSE, up 0.57 per cent from its previous close.

RECOMMENDED FOR YOU

Lupin gets USFDA nod for generic cough relief oral solution

The product is generic version of Endo Pharmaceuticals Inc's Hycodan oral solution in same strength

The product is generic version of Endo Pharmaceuticals Inc's Hycodan oral solution in same strength firm has received approval from the US health regulator for generic Hydrocodone Bitartrate and Homatropine Methylbromide oral solution used for providing relief of cough.

The company has received US Food and Administration (USFDA) approval for its generic Hydrocodone Bitartrate and Homatropine Methylbromide oral solution (Syrup) 5 mg/1.5 mg per 5 ml, said in a filing.

The product is generic version of Endo Pharmaceuticals Inc's Hycodan oral solution in the same strength, it added.

Hydrocodone Bitartrate and Homatropine Methylbromide is indicated for the symptomatic relief of cough in adults and children 6 years of age and older.

of Ltd today closed at Rs 1,440.15 per scrip on BSE, up 0.57 per cent from its previous close.
image
Business Standard
177 22

Lupin gets USFDA nod for generic cough relief oral solution

The product is generic version of Endo Pharmaceuticals Inc's Hycodan oral solution in same strength

firm has received approval from the US health regulator for generic Hydrocodone Bitartrate and Homatropine Methylbromide oral solution used for providing relief of cough.

The company has received US Food and Administration (USFDA) approval for its generic Hydrocodone Bitartrate and Homatropine Methylbromide oral solution (Syrup) 5 mg/1.5 mg per 5 ml, said in a filing.

The product is generic version of Endo Pharmaceuticals Inc's Hycodan oral solution in the same strength, it added.

Hydrocodone Bitartrate and Homatropine Methylbromide is indicated for the symptomatic relief of cough in adults and children 6 years of age and older.

of Ltd today closed at Rs 1,440.15 per scrip on BSE, up 0.57 per cent from its previous close.

image
Business Standard
177 22